Venus Concept Inc. (VERO)

NASDAQ: VERO · IEX Real-Time Price · USD
0.023 (3.45%)
At close: May 25, 2022 4:00 PM
-0.035 (-5.081%)
After-hours:May 25, 2022 6:54 PM EDT

Company Description

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.

Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.

The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system.

In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles.

The company is headquartered in Toronto, Canada.

Venus Concept Inc.
IndustryMedical Devices
SectorHealth Care
CEODomenic Serafino

Contact Details

235 Yorkland Blvd Suite 900
Toronto, Ontario M2J 4Y8
Phone877 848 8430

Stock Details

Ticker SymbolVERO
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code1409269

Key Executives

Domenic SerafinoChief Executive Officer and Director
Domenic Della PennaChief Financial Officer
Soren Maor SinayChief Operating Officer
Michael MandarelloGeneral Counsel and Corporate Secretary
Ross J. PortaroPresident of Global Sales
Anat KotlerVice President of Global Marketing and Product Management
Anna GeorgiadisVice President of Global Human Resources
Kenji ShimizuInterim Chief Innovation Officer

Latest SEC Filings

May 17, 20224Statement of changes in beneficial ownership of securities
May 12, 202210-QQuarterly report [Sections 13 or 15(d)]
May 12, 20228-KCurrent report
Apr 29, 2022SC 13G/AStatement of acquisition of beneficial ownership by individuals
Apr 26, 2022DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 26, 2022DEF 14AOther definitive proxy statements
Apr 25, 20228-KCurrent report
Apr 8, 2022S-8Securities to be offered to employees in employee benefit plans
Mar 31, 20228-KCurrent report
Mar 28, 20224Statement of changes in beneficial ownership of securities
View All SEC Filings